Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Vukanovic

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Cancer Research|August 15, 1995
Human prostatic cancer cells are sensitive to programmed (apoptotic) death induced by the antiangiogenic agent linomideJ Vukanovic, J T Isaacs
Cancer Research|April 1, 1995
Linomide inhibits angiogenesis, growth, metastasis, and macrophage infiltration within rat prostatic cancersJ Vukanovic, J T Isaacs
The Prostate|May 1, 1995
Inhibition of tumor angiogenesis and the therapeutic ability of linomide against rat prostatic cancersJ Vukanovic, B Hartley-Asp, J T Isaacs
Journal of Cardiovascular Electrophysiology|November 17, 1998
Cisapride-induced torsades de pointesJ Vitola, J Vukanovic, D M Roden
Cancer Research|August 1, 1996
Antiangiogenic treatment with linomide as chemoprevention for prostate, seminal vesicle, and breast carcinogenesis in rodentsI B Joseph, J Vukanovic, J T Isaacs
Cancer Research|April 15, 1993
Antiangiogenic effects of the quinoline-3-carboxamide linomideJ Vukanovic, A Passaniti, T Hirata, et al.
The Journal of Urology|September 1, 1997
Anti-angiogenic treatment with linomide as adjuvant to surgical castration in experimental prostate cancerB Hartley-Asp, J Vukanovic, I B Joseph, et al.
Science (New York, N.Y.)|May 12, 1995
KAI1, a metastasis suppressor gene for prostate cancer on human chromosome 11p11.2J T Dong, P W Lamb, C W Rinker-Schaeffer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 1, 1995
Implication of cell kinetic changes during the progression of human prostatic cancerR R Berges, J Vukanovic, J I Epstein, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Cancer Research|August 15, 1995
Human prostatic cancer cells are sensitive to programmed (apoptotic) death induced by the antiangiogenic agent linomideJ Vukanovic, J T Isaacs
Cancer Research|April 1, 1995
Linomide inhibits angiogenesis, growth, metastasis, and macrophage infiltration within rat prostatic cancersJ Vukanovic, J T Isaacs
The Prostate|May 1, 1995
Inhibition of tumor angiogenesis and the therapeutic ability of linomide against rat prostatic cancersJ Vukanovic, B Hartley-Asp, J T Isaacs
Journal of Cardiovascular Electrophysiology|November 17, 1998
Cisapride-induced torsades de pointesJ Vitola, J Vukanovic, D M Roden
Cancer Research|August 1, 1996
Antiangiogenic treatment with linomide as chemoprevention for prostate, seminal vesicle, and breast carcinogenesis in rodentsI B Joseph, J Vukanovic, J T Isaacs
Cancer Research|April 15, 1993
Antiangiogenic effects of the quinoline-3-carboxamide linomideJ Vukanovic, A Passaniti, T Hirata, et al.
The Journal of Urology|September 1, 1997
Anti-angiogenic treatment with linomide as adjuvant to surgical castration in experimental prostate cancerB Hartley-Asp, J Vukanovic, I B Joseph, et al.
Science (New York, N.Y.)|May 12, 1995
KAI1, a metastasis suppressor gene for prostate cancer on human chromosome 11p11.2J T Dong, P W Lamb, C W Rinker-Schaeffer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 1, 1995
Implication of cell kinetic changes during the progression of human prostatic cancerR R Berges, J Vukanovic, J I Epstein, et al.
Pageof 1